The current NIOSH Pocket Guide sets magnesite exposure limits at 10 mg/m³ total and 5 mg/m³ respirable, describes a white odorless crystalline powder, and reports eye, skin, and respiratory irritation with cough.
Source: html ↗ · saved source
Exposure Limits; Physical Description; Exposure Routes; Symptoms · 1NIOSH REL TWA 10 mg/m³ (total) TWA 5 mg/m³ (resp). Physical Description White, odorless, crystalline powder. Exposure Routes inhalation, skin and/or eye contact. Symptoms irritation eyes, skin, respiratory system; cough.
The NIOSH Pocket Guide lists inhalation and skin or eye contact as exposure routes for magnesite and identifies eye, skin, and respiratory-system irritation and cough as symptoms.
Source: html ↗ · saved source
Exposure Routes / Symptoms / Target Organs · 1Exposure Routes inhalation, skin and/or eye contact. Symptoms irritation eyes, skin, respiratory system; cough. Target Organs Eyes, skin, respiratory system.